Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Endocrine Pathology
|
February 18, 2019
Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway
Marta Szybowska, Ozgur Mete, Evan Weber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 10, 2024
Alternative immune effector cells picking up speed
Evan Weber, Marie Bleakley, James C Cronk, et al.
Current Oncology (Toronto, Ont.)
|
May 27, 2022
Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer
Michaela Bercovitch Sadinsky, Joanne Power, Enza Ambrosio, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2021
Mismatch Repair Universal Screening of Endometrial Cancers (MUSE) in a Canadian Cohort
Jessica Lawrence, Lara Richer, Jocelyne Arseneau, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
January 19, 2026
Deep intronic <i>MSH2</i> variant confirms Muir-Torre subtype of Lynch syndrome
Fiona Chan-Pak-Choon, Andrew Y Shuen, Evan Weber, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
July 3, 2026
The Impact of Pathogenic Variants of BRCA1, BRCA2 and Other DNA-Repair Genes on the Survival Benefits Conferred by PARP Inhibitors - Single Center Experience from Quebec
Xing Zeng, Gabriel Levin, Lawrie Shabazian, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
Rapid Assessment of Immune Effector Cell-mediated Cytotoxicity using mRNA Lipid Nanoparticles
Philip Mollica, Jian Li, Sang-Hoon Kim, et al.
Pediatric Blood & Cancer
|
September 13, 2018
"A change in perspective": Exploring the experiences of adolescents with hereditary tumor predisposition
Evan Weber, Cheryl Shuman, Jonathan D Wasserman, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
Transient EZH2 suppression by Tazemetostat during <i>in vitro</i> expansion maintains T cell stemness and improves adoptive T cell therapy
Yingqin Hou, Jaroslav Zak, Yujie Shi, et al.
Frontiers in Immunology
|
May 27, 2026
Rapid assessment of immune effector cell-mediated cytotoxicity using mRNA lipid nanoparticles
Philip Mollica, Jian Li, Sang-Hoon Kim, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Endocrine Pathology
|
February 18, 2019
Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway
Marta Szybowska, Ozgur Mete, Evan Weber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 10, 2024
Alternative immune effector cells picking up speed
Evan Weber, Marie Bleakley, James C Cronk, et al.
Current Oncology (Toronto, Ont.)
|
May 27, 2022
Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer
Michaela Bercovitch Sadinsky, Joanne Power, Enza Ambrosio, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2021
Mismatch Repair Universal Screening of Endometrial Cancers (MUSE) in a Canadian Cohort
Jessica Lawrence, Lara Richer, Jocelyne Arseneau, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
January 19, 2026
Deep intronic <i>MSH2</i> variant confirms Muir-Torre subtype of Lynch syndrome
Fiona Chan-Pak-Choon, Andrew Y Shuen, Evan Weber, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
July 3, 2026
The Impact of Pathogenic Variants of BRCA1, BRCA2 and Other DNA-Repair Genes on the Survival Benefits Conferred by PARP Inhibitors - Single Center Experience from Quebec
Xing Zeng, Gabriel Levin, Lawrie Shabazian, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
Rapid Assessment of Immune Effector Cell-mediated Cytotoxicity using mRNA Lipid Nanoparticles
Philip Mollica, Jian Li, Sang-Hoon Kim, et al.
Pediatric Blood & Cancer
|
September 13, 2018
"A change in perspective": Exploring the experiences of adolescents with hereditary tumor predisposition
Evan Weber, Cheryl Shuman, Jonathan D Wasserman, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
Transient EZH2 suppression by Tazemetostat during <i>in vitro</i> expansion maintains T cell stemness and improves adoptive T cell therapy
Yingqin Hou, Jaroslav Zak, Yujie Shi, et al.
Frontiers in Immunology
|
May 27, 2026
Rapid assessment of immune effector cell-mediated cytotoxicity using mRNA lipid nanoparticles
Philip Mollica, Jian Li, Sang-Hoon Kim, et al.
Page
of 3